pfizer glp-1 news Pfizer, Innovent drugs pass China insurance preliminary review Woke up to news that

Key Market Highlights The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 The market is expected to reach US$ 211.8 Billion by 2035 The industry is forecast to expand at a CAGR of 13.7% during 2025-2035 North America accounted for the largest market share of 68.4% in 2024 The Subcutaneous route of administration segment held 78.2% market share in 2024 Major industry participants include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and AstraZeneca Rising Type 2 Diabetes Cases Accelerating Market Growth The growing prevalence of type 2 diabetes remains one of the most significant growth drivers for the GLP-1 analogues market

Our inactive structure represents a snapshot of the peptide-free GLP-1R and provides insights into the activation pathway of this receptor family

A Cleveland Clinic overview of Ozempic face notes that the facial drooping associated with this process is not a chemical side effect of the medication

Fusion technology, which involves linking a target protein to a more stable protein, is one of the strategies used in protein-therapeutic optimization